{"id":399087,"date":"2020-12-14T09:04:50","date_gmt":"2020-12-14T14:04:50","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=399087"},"modified":"2020-12-14T09:04:50","modified_gmt":"2020-12-14T14:04:50","slug":"tauriga-sciences-inc-surpasses-the-10000-followers-threshold-on-its-instagram-page-taurigum","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tauriga-sciences-inc-surpasses-the-10000-followers-threshold-on-its-instagram-page-taurigum\/","title":{"rendered":"Tauriga Sciences Inc. Surpasses the 10,000 Follower(s) Threshold on its Instagram Page – @taurigum"},"content":{"rendered":"
\n

The \u201cSwipe Up\u201d Feature has been Activated, Enhancing the Company\u2019s E-Commerce Business<\/p>\n

NEW YORK, NY, Dec. 14, 2020 (GLOBE NEWSWIRE) — via NewMediaWire<\/a>\u00a0<\/u>— Tauriga Sciences, Inc. (OTCQB:\u00a0TAUG) (\u201cTauriga\u201d or the \u201cCompany\u201d), a revenue generating, diversified life sciences company, with a proprietary line of functional \u201csupplement\u201d chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as two ongoing Biotechnology initiatives, today confirmed that the Company has achieved an important corporate milestone.\u00a0\u00a0The Company has reached and surpassed the 10,000 Follower(s) Threshold (the \u201cThreshold\u201d) on its Instagram Page: @taurigum (Link:\u00a0https:\/\/www.instagram.com\/taurigum\/<\/a>).\u00a0\u00a0As a result, the \u201cSwipe Up\u201d mechanism has been activated, which has the potential to materially benefit the Company\u2019s fast growing E-Commerce business segment.\u00a0\u00a0<\/p>\n

The Company\u2019s Instagram Page, @taurigum, was launched during August 2019.\u00a0\u00a0Since then, the Company has steadily accrued a loyal base of Followers \u2013 mainly through the launch of a broad array of innovative products.\u00a0The Company has noticed an acceleration in its Instagram Follower(s) to coincide with the recent surge in its E-Commerce business.<\/p>\n

The 10,000 Instagram Follower(s) milestone comes with immediate, tangible benefits.\u00a0\u00a0Once this Threshold has been reached, Instagram makes it easier to drive traffic to an E-Commerce website via Stories with the \u201cSwipe Up\u201d to Link Feature.\u00a0\u00a0This enables web traffic to be directed to your E-Commerce page, email sign-up list, without requiring the visitor to Click your bio first.\u00a0\u00a0This Feature Alone is a Game Changer!<\/p>\n

\n ABOUT TAURIGA SCIENCES INC.<\/strong>\n <\/p>\n

Tauriga Sciences, Inc. (TAUG) is a revenue generating, diversified life sciences company, engaged in several major business activities and initiatives.\u00a0\u00a0The company manufactures and distributes several proprietary retail products and product lines, mainly focused on the Cannabidiol (\u201cCBD\u201d) and Cannabigerol (\u201cCBG\u201d) Edibles market segment.\u00a0\u00a0The main product line, branded as Tauri-Gum\u2122, consists of a proprietary supplement chewing gum that is Kosher certified, Halal certified, and Vegan Formulated (CBD Infused Tauri-Gum\u2122 Flavors: Mint, Blood Orange, Pomegranate), (CBG Infused Tauri-Gum\u2122 Flavors: Peach-Lemon, Black Currant) & (Vitamin C + Zinc \u201cImmune Booster\u201d Tauri-Gum\u2122 Flavor: Pear Bellini).\u00a0\u00a0The Company\u2019s commercialization strategy consists of a broad array of retail customers, distributors, and a fast-growing E-Commerce business segment (E-Commerce website: www.taurigum.com). Please visit our corporate website, for additional information, as well as inquiries, at\u00a0http:\/\/www.tauriga.com<\/p>\n

Complementary to the Company\u2019s retail business, are its two ongoing biotechnology initiatives.\u00a0\u00a0The first one relates to the development of a Pharmaceutical grade version of Tauri-Gum\u2122, for nausea regulation (specifically designed to help patients that are subjected to ongoing chemotherapy treatment).\u00a0On March 18, 2020, the Company announced that it filed a provisional U.S. patent application covering its pharmaceutical grade version of Tauri-Gum\u2122.\u00a0\u00a0The Patent, filed with the U.S.P.T.O. is Titled \u201cMEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT\u201d.\u00a0The second one relates to a collaboration agreement with Aegea Biotechnologies Inc. for the co-development of a rapid, multiplexed, Novel Coronavirus (COVID-19) test with superior sensitivity and selectivity.\u00a0\u00a0\u00a0<\/p>\n

On October 6, 2020, the Company announced that it has been approved to operate as a U.S. Government Vendor (CAGE CODE # 8QXV4)<\/p>\n

On October 7, 2020 the Company disclosed a Strategic Alliance with Think BIG, LLC, Social Impact Startup Founded by CJ Wallace, Son of Christopher \u201cThe Notorious B.I.G.\u201d Wallace.<\/p>\n

The Company is headquartered in New York City and operates a regional office in Barcelona, Spain.\u00a0\u00a0In addition, the Company operates a full time E-Commerce fulfillment center located in LaGrangeville, New York.<\/p>\n

\n DISCLAIMER — Forward-Looking Statements<\/strong>\n <\/p>\n

This press release contains certain \u201cforward-looking statements\u201d as defined by the Private Securities Litigation Reform Act of 1995 which represent management\u2019s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as \u201cmay,\u201d \u201cwill,\u201d \u201cexpects,\u201d \u201canticipates,\u201d believes, \u201chopes,\u201d \u201cbelieves,\u201d or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management\u2019s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in\u00a0\u00a0forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the \u201cRisk Factors\u201d section of Tauriga\u2019s Form 10-K and other filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not place undue reliance on these forward-looking statements.<\/p>\n

\n Contact:<\/strong>\n <\/p>\n

Tauriga Sciences, Inc.<\/p>\n

555 Madison Avenue, 5th Floor<\/p>\n

New York, NY\u00a0\u00a010022<\/p>\n

Chief Executive Officer<\/p>\n

Mr. Seth M. Shaw<\/p>\n

Email:\u00a0\u00a0sshaw@tauriga.com<\/p>\n

cell # (917) 796 9926<\/p>\n

Instagram: @taurigum<\/p>\n

Twitter: @SethMShaw<\/p>\n

Corp. Website:\u00a0\u00a0\u00a0www.tauriga.com<\/p>\n

E-Commerce Website:\u00a0\u00a0www.taurigum.com<\/a><\/p>\n

\n Attachment<\/strong>\n <\/p>\n